Effects of DPP‐4 inhibitors, GLP‐1 receptor agonists, SGLT‐2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta‐analyses‐driven approach.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 8, p. 1, doi. 10.1111/dme.15157
- By:
- Publication type:
- Article